Clorox Files 8-K Report

TL;DR

CLX filed an 8-K, likely financial updates. Stay tuned.

AI Summary

On September 10, 2024, The Clorox Company filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating potential updates or disclosures related to the company's financial performance or significant business events. No specific dollar amounts or new material events were detailed in the provided excerpt.

Why It Matters

This filing signals that The Clorox Company is providing updated financial information or disclosing material events to the SEC, which could impact investor understanding of the company's current status.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for financial statements and exhibits, not indicating immediate significant risk or change.

Key Players & Entities

• The Clorox Company (company) — Registrant
• 0000021076 (company) — Central Index Key
• 2842 (company) — Standard Industrial Classification
• DE (company) — State of Incorporation
• 0630 (company) — Fiscal Year End
• 1-07151 (company) — SEC File Number
• 31-0595760 (company) — IRS Employer Identification No.
• 1221 Broadway, Oakland, California 94612-1888 (company) — Business Address
• 5102717000 (company) — Business Phone
• P.O. Box 24305, Oakland, California 94612-1305 (company) — Mail Address

FAQ

From the Filing

0001206774-24-000894.txt : 20240910 0001206774-24-000894.hdr.sgml : 20240910 20240910162132 ACCESSION NUMBER: 0001206774-24-000894 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240910 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240910 DATE AS OF CHANGE: 20240910 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CLOROX CO /DE/ CENTRAL INDEX KEY: 0000021076 STANDARD INDUSTRIAL CLASSIFICATION: SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS [2842] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 310595760 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-07151 FILM NUMBER: 241290337 BUSINESS ADDRESS: STREET 1: THE CLOROX COMPANY STREET 2: 1221 BROADWAY CITY: OAKLAND STATE: CA ZIP: 94612-1888 BUSINESS PHONE: 5102717000 MAIL ADDRESS: STREET 1: P.O. BOX 24305 CITY: OAKLAND STATE: CA ZIP: 94612-1305 8-K 1 clx4377971-8k.htm CURRENT REPORT false 0000021076 0000021076 2024-09-10 2024-09-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 10, 2024 THE CLOROX COMPANY (Exact name of registrant as specified in its charter)   Delaware 1-07151 31-0595760 (State or other jurisdiction of (Commission File Number) (I.R.S. Employer incorporation)   Identification No.) 1221 Broadway , Oakland , California 94612-1888 (Address of principal executive offices) (Zip code) ( 510 ) 271-7000 (Registrant's telephone number, including area code) Not applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   [ ] Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)     [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock - $1.00 par value CLX New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2). Emerging growth company      ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ☐   1   Item 7.01 Regulation FD Disclosure On September 10, 2024, The Clorox Company issued a press release announcing the completion of the divestiture of its Better Health Vitamins, Minerals and Supplements business. The full text of the press release related to the sale is attached hereto as Exhibit 99.1. Item 9.01 Financial Statements and Exhibits (d) Exhibits See the Exhibit Index below. EXHIBIT INDEX Exhibit   Description 99.1   Press Release dated September 10, 2024 of The Clorox Company 104   Cover Page Interactive Data File (embedded within the Inline XBRL document) 2   SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be